Cite
Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation.
MLA
Gu, Zili, et al. “Enhancing Anti-Tumor Immunity through Liposomal Oxaliplatin and Localized Immunotherapy via STING Activation.” Journal of Controlled Release, vol. 357, May 2023, pp. 531–44. EBSCOhost, https://doi.org/10.1016/j.jconrel.2023.04.011.
APA
Gu, Z., Hao, Y., Schomann, T., Ossendorp, F., ten Dijke, P., & Cruz, L. J. (2023). Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation. Journal of Controlled Release, 357, 531–544. https://doi.org/10.1016/j.jconrel.2023.04.011
Chicago
Gu, Zili, Yang Hao, Timo Schomann, Ferry Ossendorp, Peter ten Dijke, and Luis J. Cruz. 2023. “Enhancing Anti-Tumor Immunity through Liposomal Oxaliplatin and Localized Immunotherapy via STING Activation.” Journal of Controlled Release 357 (May): 531–44. doi:10.1016/j.jconrel.2023.04.011.